SCHEMBL29324155

SCHEMBL29324155

COC(=O)c1ccc(C2CN(CC(F)F)CCN2C(=O)OC(C)(C)C)cc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 7/20 0.47
NR1H3 Q13133 7/20 0.47
PDE4B Q07343 4/20 0.36
CALCA P06881 1/20 0.36
CCR3 P51677 1/20 0.35
EED O75530 1/20 0.35
RBBP4 Q09028 1/20 0.35
SUZ12 Q15022 1/20 0.35
EZH2 Q15910 1/20 0.35
AEBP2 Q6ZN18 1/20 0.35
USP30 Q70CQ3 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK4 Q16654 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
DPP4 P27487 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29324569 0.84 TMEM97 (0.47) PDE4BPDK2PDK4
SCHEMBL28961486 0.80 NR1H2 (0.48) NR1H2NR1H3USP30CA12CA1
SCHEMBL29326266 0.79 NR1H2 (0.47) NR1H2NR1H3EEDRBBP4SUZ12
SCHEMBL31056568 0.78 PDE4B (0.42) NR1H2NR1H3PDE4BPDK2PDK4
SCHEMBL29321333 0.77 NR1H2 (0.47) NR1H2NR1H3PDE4BCALCATACR1
SCHEMBL31056552 0.77 CFB (0.40)
SCHEMBL31056740 0.77 NR1H2 (0.49) NR1H2NR1H3PDE4BPDK2PDK4
SCHEMBL29321108 0.76 NR1H2 (0.46) NR1H2NR1H3PDE4BCALCATACR1
SCHEMBL29320347 0.76 ALDH1A1 (0.38) NR1H2NR1H3PDE4B
SCHEMBL29323240 0.75 CA12 (0.39) CA12CA1CA2CA7PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed